The Use of Oral Anticoagulation Is Not Associated With a Reduced Risk of Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis of Cohort Studies

Background: Hypercoagulability and thromboembolic events are associated with poor prognosis in coronavirus disease 2019 (COVID-19) patients. Whether chronic oral anticoagulation (OAC) improve the prognosis is yet controversial. The present study aimed to investigate the association between the chron...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Meng-Fei, Guo, Si-Tong, Ke, Yi-Jun, Wang, Bao-Yan, Yu, Feng, Xu, Hang, Gu, Zhi-Chun, Ge, Wei-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008218/
https://www.ncbi.nlm.nih.gov/pubmed/35431952
http://dx.doi.org/10.3389/fphar.2022.781192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008218/
https://www.ncbi.nlm.nih.gov/pubmed/35431952
http://dx.doi.org/10.3389/fphar.2022.781192

Ejemplares similares